Skip to main content

Table 4 Demographics and clinical characteristics of patients with Kawasaki disease shock syndrome and septic shock group (continuous variables were described as median and range)

From: Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study

  KDSS (n=13) SS (n=29) P value
Age, (years) 5.1 (0.5–10.6) 7.6 (0.3–19.9) 0.185
Male (%) 46.2% (6/13) 65.5% (19/29) 0.237
Fever duration (days) 11 (8–23) 7 (1–114) 0.068
Total hospital day (days) 18 (6–31) 13 (7–225) 0.419
Follow up duration (months) 10 (1–105) 2.5 (0–119) 0.124
ICU care (%) 53.8% (7/13) 62.1% (18/29) 0.616
ICU care duration (days) 4 (0–11) 3 (0–20) 0.591
Inotropic drugs (%) 92.3% (12/13)§ 86.2% (25/29) 0.153
Respiratory support
 - No support 30.8% (4/13) 48.3% (14/29) 0.289
 - Oxygen delivery 53.8% (7/13) 10.3% (3/29) 0.005
 - Mechanical ventilation 15.4% (2/13) 41.4%(12/29) 0.159
Mortality (%) 0.0% (0/13) 10.3%(3/29) 0.540
  1. KDSS Kawasaki disease shock syndrome, KD Kawasaki disease, SS Septic shock and toxic shock syndrome, ICU Intensive care unit